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from 4–23 with the greatest variety in the mid-range. A small
number of proﬁles usually accounted for the majority that
occurred at each score. Differences in functioning were observed
across 2–5 ADLs at scores of 5–15 and 90–95, and across 7–9
ADLs at scores of 20–85. CONCLUSIONS: Only a fraction
(5%) of possible BI proﬁles occur clinically in stroke. Patients
with the same BI scores may vary in ADL functioning and require
different levels of clinical management. Depending on how ADLs
are valued, preferences for disability states within scores may
vary. In clinical trials, scores alone may not capture treatment
effects that are important to patients. Properly adapted, a 
preference-based BI may constitute a more sensitive measure of
effect than scores.
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OBJECTIVES: To examine the relationship between health
insurance type and prescribed drug costs for orthopedic outpa-
tients of a regional hospital in southern Thailand. METHODS:
Electronic data for 3117 prescriptions for osteoarthritis (OA)
and rheumatoid arthritis (RA) new patients, whose age was 40
years or older and obtained their outpatient prescriptions from
October 1, 2001 to September 30, 2002, were analyzed. Descrip-
tive and linear regression analyses were used to analyze overall
and subgroup (OA and RA) data. RESULTS: Results showed
94.6% of the patients had osteoarthritis. They were divided into
three groups of health insurance type, which were Civil Servant
Medical Beneﬁt Scheme (CSMBS), Universal Coverage Scheme
(UC), and Social Security Scheme (SSS). While the SSS and UC
schemes paid by capitation basis, the CSMBS did by fee-for-
service basis. The CSMBS and SSS patients received higher
average cost per prescription and average cost per day than did
the UC patients. The RA patients obtained more expensive drugs
than did the OA patients. For OA patients, the CSMBS patients
had the lowest number of drugs per prescription. However, the
average cost per prescription and average cost per day of the
CSMBS and SSS patients were signiﬁcantly higher than those of
the UC patients. For RA patients, the average cost per prescrip-
tion and average cost per day of the UC patients were less than
those of the CSMBS and SSS patients, while their numbers of
drugs per prescription were slightly different. The regression
analysis for all patients and each subgroup showed signiﬁcant
relationship between the patients’ health insurance type and
average cost per prescription and average cost per day. CON-
CLUSIONS: A signiﬁcant relationship between the health insur-
ance type and prescription drug costs was found. The UC
patients tended to receive less expensive drugs than did the
others.
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OBJECTIVES: To promote rational drug use, governments may
apply various instruments to aid health care professionals in clin-
ical decision-making. Guidelines are a common approach, but
their impact on clinical practice is often limited. Therefore the
Dutch government sometimes applies a stronger instrument: con-
ditional reimbursement enforced by law, applied to drug groups
listed on the so-called “Annex 2”. We assessed process and 
outcomes of this instrument. METHODS: We quantitatively
explored the effects of conditional reimbursement on drug use
and costs for 33 Annex 2-drugs using the national GIP-database
that administers funding decisions for people in insurance
schemes. The qualitative process evaluation used document
analyses, interviews (N = 70), and case studies (N = 6) to map
perceptions of patients, physicians, pharmacists, insurers, man-
ufacturers, and policy makers to attain insights into the perfor-
mance of Annex 2. In focus groups we triangulated ﬁndings and
identiﬁed improvements. RESULTS: The quantitative analysis
showed that effects of conditional reimbursement varied with
type of conditions and clinical setting. People responsible for
implementation complained about administrative burden and
lack of means to monitor if conditions for reimbursement were
met (e.g. statins). An additional problem is that Annex 2 condi-
tions lag behind evolving clinical knowledge (e.g. clopidogrel).
The way in which conditions were operationalised appeared
crucial for their implementation. When stakeholders had been
actively involved in their operationalisation (e.g. TNF-b-block-
ers) implementation was successful, lack of consensus on the
conditions was detrimental to effectiveness of Annex 2 policy.
CONCLUSIONS: Overall, Annex 2 is considered a necessary
instrument, although there are conditions to be met for a more
effective functioning in the near future. There is a demand for
more dynamic and pro-active communication strategy by the dif-
ferent Annex 2-actors to increase awareness of the existing policy
and to narrow the gap between the clinical practice and policy
regarding registration and reimbursement of drugs.
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There is a global need for education in the ﬁeld of pharma-
coeconomics (PE). One is provided by Colleges of Pharmacy
(COP’s). Several surveys were conducted during the 1990’s to
determine the extent of pharmacoeconomic education at US-
based COP’s. One survey found that by 1999, 90% of US COP’s
provided PE education. On the other hand, only one study, con-
ducted in 1997, was found that surveyed Non-US COP’s. A total
of 112 Non-US COP’s in 44 countries were surveyed via e-mail;
41 COP’s from 25 countries responded. Seventeen COP’s from
13 countries reported providing PE education. OBJECTIVE: The
objective of this study was to perform a follow-up study for Non-
US COP’s. METHODS: During January—May, 2004, surveys
were sent to 291 Non-US COP’s in 42 countries via e-mail using
information from the World List of Pharmacy Schools (WLPS).
Follow-up e-mails were sent to non-respondents and to respon-
dents when clariﬁcations of their responses were needed.
RESULTS: A total of 89 COP’s from 42 countries provided
usable responses. A total of 46 COP’s from 28 countries indi-
cated that they provided PE education. Of these 46 COP’s, nine
provided education at the professional level only, 15 at the grad-
uate level only and 22 at both levels. The median number of stu-
dents enrolled at the professional level was 100, and 15 at the
graduate level. The median number of class contact hours for PE
education was 12 for professional students and 15 for graduate
students. CONCLUSIONS: Fifty-one percent (51%)of respon-
dents provided PE education compared to 41% from the 1997
survey. The majority of Non-US COP’s that offered PE educa-
